ArticleInfectious diseases of poverty2025
Building a tool to assess malaria surveillance and response capacity in malaria post-elimination contexts: a modified and dual-weighted Delphi approach.
Article in Infectious diseases of poverty, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A county-level indicator framework for assessing schistosomiasis transmission risk in post-transmission-interruption China.Infectious diseases of poverty · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundSustaining the elimination of malaria requires robust surveillance to prevent reintroduction, but standardized frameworks for assessing the surveillance capacity of a country post-elimination are lacking. This study aims to develop a standardized framework for assessing malaria surveillance and response capacity in countries that have eliminated malaria.
methodsWe developed a malaria surveillance and response assessment framework through a three-stage process. First, two systematic reviews were conducted to identify indicators used in post-elimination settings worldwide and specifically in China. The candidate indicators were refined through expert panel discussions, which yielded 45 indicators across six domains. Next, a modified two-round Delphi process was conducted, involving 30 experts in epidemiology, disease control, and public health from diverse institutions and administrative levels. The experts rated the importance and feasibility of the indicators using structured questionnaires and then engaged in group discussions to contextualize the findings. Indicator weights were determined using a combined analytic hierarchy process (AHP) and entropy methods.
resultsThe systematic reviews and expert consultations identified 45 candidate indicators. After two rounds of expert consultation, a framework comprising 34 indicators across six domains for assessing malaria surveillance and response capacity in post-elimination settings was developed. The weights of the six domains are as follows: surveillance system coverage and performance (0.240); the quality and use of the surveillance data (0.3710); the functioning of the information management system (0.0973); the availability and adequacy of resources (0.0375); early diagnosis and treatment (0.1571); and quality control supervision and training (0.0973). The expert authority coefficient (Cr) values of the first and second rounds were 0.777 and 0.895 respectively. Of the 34 indicators, the proportion of confirmed cases with completed epidemiological investigations and submitted reports (0.1153) and the interval between the first medical visit and diagnosis (0.1131) had the highest weights.
conclusionThis consensus-based framework provides a standardized tool for evaluating malaria surveillance and response capacity in post-elimination settings. Adoption of the framework could help countries monitor and improve their systems to sustain elimination of the disease, mitigate reintroduction risks, and support global malaria eradication efforts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.